<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129973">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01410006</url>
  </required_header>
  <id_info>
    <org_study_id>10-1036</org_study_id>
    <nct_id>NCT01410006</nct_id>
  </id_info>
  <brief_title>Neurofibromatosis Type 1 Patient Registry</brief_title>
  <acronym>NPRI</acronym>
  <official_title>Neurofibromatosis Type 1 Patient Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Neurofibromatosis Type 1 (NF1) Patient Registry Initiative (NPRI) is a web-based
      registry that asks participants to fill out a 30-minute online questionnaire to collect
      information about the spectrum of medical and social problems experienced by children and
      adults with NF1. The information gained from your participation may one day help doctors
      develop personalized treatments for individuals living with NF1.

      We are currently enrolling individuals with NF1 who either (1) HAVE previously been
      diagnosed with a brain tumor younger than 18 years or (2) HAVE NEVER had a brain tumor.
      Please note: there is no therapy associated with this study. Individuals may participate in
      the registry by going to https://nf1registry.wustl.edu/
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">December 2040</completion_date>
  <primary_completion_date type="Anticipated">December 2040</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <target_duration>50 Years</target_duration>
  <primary_outcome>
    <measure>Neurofibromatosis Type 1</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Neurofibromatosis Type 1</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is all individuals diagnosed with Neurofibromatosis Type 1.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals diagnosed by a healthcare provider with Neurofibromatosis Type 1

        Exclusion Criteria:

          -  Individuals without a healthcare provider diagnosis of Neurofibromatosis Type 1
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly J Johnson, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly J Johnson, MPH, PhD</last_name>
    <phone>314-935-9154</phone>
    <email>nf1registry@brownschool.wustl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly J Johnson, PhD</last_name>
      <phone>314-935-9154</phone>
      <email>kijohnson@brownschool.wustl.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://nf1registry.wustl.edu</url>
    <description>Link to NF1 registry enrollment page</description>
  </link>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 31, 2016</lastchanged_date>
  <firstreceived_date>August 2, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NF1</keyword>
  <keyword>neurofibromatosis</keyword>
  <keyword>NF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neurofibromatoses</mesh_term>
    <mesh_term>Neurofibroma</mesh_term>
    <mesh_term>Neurofibromatosis 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
